دورية أكاديمية
أعرض في EDS

REM sleep behavior disorder, as assessed by questionnaire, in G2019S LRRK2 mutation PD and carriers.

التفاصيل البيبلوغرافية
العنوان: REM sleep behavior disorder, as assessed by questionnaire, in G2019S LRRK2 mutation PD and carriers.
المؤلفون: Saunders-Pullman R; Department of Neurology, Mount Sinai Beth Israel Medical Center, New York, New York, USA.; Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Alcalay RN; Department of Neurology, College of Physicians and Surgeons, Columbia University, New York, NY, USA.; Taub Institute for Research on Alzheimer's Disease and the Aging Brain, College of Physicians and Surgeons, Columbia University, New York, NY, USA., Mirelman A; Movement Disorders Unit, Department of Neurology, Tel-Aviv Medical Center, Sieratzki Chair of Neurology, Department of Neurology and Neurosurgery, Sackler School of Medicine, Sagol School of Neuroscience, Tel-Aviv University, Tel-Aviv, Israel., Wang C; Department of Epidemiology and Social Medicine, Albert Einstein College of Medicine, Bronx, New York, USA., Luciano MS; Department of Neurology, University of California San Francisco, San Francisco, California, USA., Ortega RA; Department of Neurology, Mount Sinai Beth Israel Medical Center, New York, New York, USA., Glickman A; Department of Neurology, Mount Sinai Beth Israel Medical Center, New York, New York, USA., Raymond D; Department of Neurology, Mount Sinai Beth Israel Medical Center, New York, New York, USA., Mejia-Santana H; Department of Neurology, College of Physicians and Surgeons, Columbia University, New York, NY, USA., Doan N; Department of Neurology, Mount Sinai Beth Israel Medical Center, New York, New York, USA., Johannes B; Department of Neurology, Mount Sinai Beth Israel Medical Center, New York, New York, USA., Yasinovsky K; Movement Disorders Unit, Department of Neurology, Tel-Aviv Medical Center, Sieratzki Chair of Neurology, Department of Neurology and Neurosurgery, Sackler School of Medicine, Sagol School of Neuroscience, Tel-Aviv University, Tel-Aviv, Israel., Ozelius L; Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Department of Genetics, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Clark L; Taub Institute for Research on Alzheimer's Disease and the Aging Brain, College of Physicians and Surgeons, Columbia University, New York, NY, USA.; Department of Pathology and Cell Biology, College of Physicians and Surgeons, Columbia University, New York, New York, USA., Orr-Utreger A; Genetic Institute, Tel-Aviv Medical Center, Sackler School of Medicine, Sagol School of Neuroscience, Tel-Aviv University, Tel-Aviv, Israel., Marder K; Department of Neurology, College of Physicians and Surgeons, Columbia University, New York, NY, USA.; Taub Institute for Research on Alzheimer's Disease and the Aging Brain, College of Physicians and Surgeons, Columbia University, New York, NY, USA.; Gertrude H. Sergievsky Center, College of Physicians and Surgeons, Columbia University, New York, New York, USA.; Department of Psychiatry, Columbia University Medical Center, New York, New York, USA., Giladi N; Movement Disorders Unit, Department of Neurology, Tel-Aviv Medical Center, Sieratzki Chair of Neurology, Department of Neurology and Neurosurgery, Sackler School of Medicine, Sagol School of Neuroscience, Tel-Aviv University, Tel-Aviv, Israel., Bressman SB; Department of Neurology, Mount Sinai Beth Israel Medical Center, New York, New York, USA.; Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
مؤلفون مشاركون: AJ LRRK2 Consortium
المصدر: Movement disorders : official journal of the Movement Disorder Society [Mov Disord] 2015 Nov; Vol. 30 (13), pp. 1834-9. Date of Electronic Publication: 2015 Sep 14.
نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
اللغة: English
بيانات الدورية: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 8610688 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1531-8257 (Electronic) Linking ISSN: 08853185 NLM ISO Abbreviation: Mov Disord Subsets: MEDLINE
أسماء مطبوعة: Publication: <2001->: New York, NY : Wiley-Liss
Original Publication: [New York, N.Y.] : Raven Press, [c1986-
مواضيع طبية MeSH: Surveys and Questionnaires*, Glutamine/*genetics , Mutation/*genetics , Parkinson Disease/*diagnosis , Parkinson Disease/*genetics , Protein Serine-Threonine Kinases/*genetics , Serine/*genetics , Sleep Deprivation/*genetics, Adult ; Aged ; Female ; Humans ; Judaism ; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2 ; Male ; Middle Aged ; Sleep Deprivation/diagnosis
مستخلص: Background: Rapid eye movement sleep behavior disorder occurs with idiopathic Parkinson's disease (PD) and often precedes PD. Its frequency in LRRK2-PD and utility as a preclinical marker has not been established.
Methods: One hundred forty-four idiopathic PD, 142 LRRK2 G2019S mutation PD, 117 non-manifesting carriers, 93 related noncarriers, and 40 healthy controls completed the Rapid eye movement sleep Behavior Disorder Screening Questionnaire.
Results: Cut scores were met by 30.6% idiopathic PD, 19.7% LRRK2-PD, 6% nonmanifesting carriers, 20.4% related noncarriers, and 15% controls. The likelihood of abnormal scores was decreased in LRRK2-PD versus idiopathic PD (odds ratio = 0.55, P = 0.03), nonmanifesting carriers versus related noncarriers (OR = 0.25, P < 0.01), and PD of less than 3 years' duration, 1 of 19 LRRK2-PD versus 14 of 41 idiopathic PD (P < 0.05).
Conclusions: A lower frequency of abnormal questionnaire scores is seen in LRRK2-PD, especially in early LRRK2-PD, and in nonmanifesting carriers. Therefore, the Rapid eye movement sleep Behavior Disorder Questionnaire is unlikely to serve as a preclinical marker for phenoconversion to PD.
(© 2015 International Parkinson and Movement Disorder Society.)
References: Neuropathol Appl Neurobiol. 2012 Feb;38(1):4-24. (PMID: 22074330)
Mov Disord. 2011 Sep;26(11):2026-31. (PMID: 21611983)
Parkinsonism Relat Disord. 2010 Feb;16(2):105-8. (PMID: 19716333)
Ann Neurol. 2009 Jul;66(1):39-47. (PMID: 19670440)
Lancet Neurol. 2013 May;12(5):443-53. (PMID: 23562390)
Sleep Med. 2013 Aug;14(8):763-7. (PMID: 23058689)
Neurology. 1990 Oct;40(10):1529-34. (PMID: 2215943)
PLoS One. 2014 Oct 17;9(10):e108982. (PMID: 25330404)
Neurology. 2002 Aug 27;59(4):585-9. (PMID: 12196654)
Neurology. 2007 Nov 6;69(19):1843-9. (PMID: 17984452)
Mov Disord. 2011 Jul;26(8):1537-41. (PMID: 21469205)
Mov Disord. 2006 Apr;21(4):462-6. (PMID: 16228998)
J Neurol Neurosurg Psychiatry. 2008 Oct;79(10):1117-21. (PMID: 18682443)
JAMA Neurol. 2015 Jan;72(1):100-5. (PMID: 25401511)
N Engl J Med. 2006 Jan 26;354(4):424-5. (PMID: 16436782)
Sleep Med. 2015 Jan;16(1):186-9. (PMID: 25534709)
Ann Clin Transl Neurol. 2014 Sep;1(9):670-8. (PMID: 25493281)
Neurobiol Aging. 2014 May;35(5):1125-31. (PMID: 24355527)
Sleep Med. 2013 Aug;14(8):754-62. (PMID: 23474058)
Mov Disord. 2010 Oct 30;25(14):2304-10. (PMID: 20669316)
Mov Disord. 2008 Sep 15;23(12):1665-72. (PMID: 18709686)
J Mol Neurosci. 2012 May;47(1):139-43. (PMID: 22194196)
Sleep Med. 2011 Aug;12(7):711-3. (PMID: 21700495)
Tremor Other Hyperkinet Mov (N Y). 2014 Jun 23;4:245. (PMID: 25009765)
Sleep Med. 2007 Nov;8(7-8):779-83. (PMID: 17904419)
J Neurol. 2008 Feb;255(2):192-6. (PMID: 18217187)
Mov Disord. 2015 Jun;30(7):981-6. (PMID: 25809001)
Neurology. 2015 Mar 3;84(9):888-94. (PMID: 25663225)
Mov Disord. 2013 Dec;28(14):1966-71. (PMID: 24243757)
Mov Disord. 2012 Apr 15;27(5):617-26. (PMID: 22508280)
Lancet Neurol. 2008 Jul;7(7):583-90. (PMID: 18539534)
Mov Disord. 2007 Dec;22(16):2386-93. (PMID: 17894337)
Sleep Med. 2013 Aug;14(8):744-8. (PMID: 23347909)
J Neurol Sci. 2001 May 1;186(1-2):7-11. (PMID: 11412865)
Neurology. 2009 Apr 14;72(15):1296-300. (PMID: 19109537)
Prog Neurobiol. 2011 Dec;95(4):629-35. (PMID: 21930184)
Neurology. 2015 Jul 7;85(1):89-95. (PMID: 26062626)
Parkinsonism Relat Disord. 2015 Feb;21(2):106-10. (PMID: 25434972)
معلومات مُعتمدة: K02 NS080915 United States NS NINDS NIH HHS; P50 NS038370 United States NS NINDS NIH HHS; P50 AG008702 United States AG NIA NIH HHS; K02 NS073836 United States NS NINDS NIH HHS; R01 NS060113 United States NS NINDS NIH HHS; R01 NS073872 United States NS NINDS NIH HHS; K02-NS073836 United States NS NINDS NIH HHS; UL1 TR000040 United States TR NCATS NIH HHS; R56 NS036630 United States NS NINDS NIH HHS; P01 NS037409 United States NS NINDS NIH HHS; U01 NS052592 United States NS NINDS NIH HHS; UL1 RR024156 United States RR NCRR NIH HHS; R21 NS050487 United States NS NINDS NIH HHS; NINDS 10628097 United States PHS HHS; R21 NS075881 United States NS NINDS NIH HHS; R01 NS036630 United States NS NINDS NIH HHS; R01 DC011805 United States DC NIDCD NIH HHS
فهرسة مساهمة: Investigator: VL Shanker; M Groves; C Palmese; E Deegan; A Drobnis; J Ratliff; L Severt; N Lubarr; R Sachdev; A Pomerantz; S Fahn; L Cote; P Greene; C Waters; P Mazzoni; O Levy; MX Tang; B Rakitin; E Roos; MO Riley; L Rosado; C Moskowitz; T Dorovski; X Liu; S Kisselev; I Peer; V Vacic; Y Balash; S Hertzel; A Hillel; H Kobo; N Bregman; M Kestenbaum; T Hendler; H Lehrman; EE Sapir; M Zelis; M Shtaigman; E Shimony; M Victor; M Grumberg; O Assais
Keywords: LRRK2; Parkinson's disease; RBDSQ; REM Behavior Disorder; preclinical
المشرفين على المادة: 0RH81L854J (Glutamine)
452VLY9402 (Serine)
EC 2.7.11.1 (LRRK2 protein, human)
EC 2.7.11.1 (Leucine-Rich Repeat Serine-Threonine Protein Kinase-2)
EC 2.7.11.1 (Protein Serine-Threonine Kinases)
تواريخ الأحداث: Date Created: 20150915 Date Completed: 20161012 Latest Revision: 20240610
رمز التحديث: 20240610
مُعرف محوري في PubMed: PMC4715645
DOI: 10.1002/mds.26413
PMID: 26366513
قاعدة البيانات: MEDLINE
الوصف
تدمد:1531-8257
DOI:10.1002/mds.26413